Literature DB >> 18638088

Vascular access for hemodialysis: experience of a team of nephrologists.

Rodolfo Stanziale1, Massimo Lodi, Enrico D'Andrea, Tonino D'Andrea.   

Abstract

A survey conducted by Bonucchi et al. underlined the different types of doctors placing arteriovenous fistula (AVF) for hemodialysis in the United States and Europe (in particular Italy). In fact, nephrologists definitely prevail in Italy, where almost 48.8% of nephrologists place an AVF themselves or with the help of a vascular surgeon (26.4%). In Europe, only 35% do so, whereas 89% of AVF are performed by surgeons in the United States. In 98% of the cases occurring at our center, the AVF was placed and reviewed by the nephrologists. This paper reports surgery cases related to the period between January 1983 and September 2006. Over this time, 1386 operations for placing and reviewing vascular access were conducted. Among these, 47 (3.3%) were related to a cuffed central venous catheter (CVC); 1138 (80.2%) related to a distal AVF; 201 (10.6%) related to a proximal AVF; and 51 (3.6%) related to an arteriovenous graft (AVG). In addition, 33 (2.3%) operations performed before January 1983 relating to AV Scribner shunts were included. Arteriovenous fistulas or AVGs were provided to our patients (only 2.6% of them have a CVC), and AVF rescue operations were performed in the shortest possible time with advantages for the patient and his vascular access.

Entities:  

Mesh:

Year:  2008        PMID: 18638088     DOI: 10.1111/j.1542-4758.2008.00276.x

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  1 in total

1.  Interventional nephrology: current status and clinical impact in Japan.

Authors:  Masato Ikeda; Hiroyuki Terawaki; Eiichiro Kanda; Maiko Furuya; Yudo Tanno; Masatsugu Nakao; Yukio Maruyama; Masutaka Maeda; Chieko Higuchi; Tsutomu Sakurada; Tomohiro Kaneko; Hiroaki Io; Koji Hashimoto; Atsushi Ueda; Keita Hirano; Naoki Washida; Hiraku Yoshida; Kazuhiro Yoshikawa; Yoshihiro Taniyama; Kenji Harada; Nanae Matsuo; Ichiro Okido; Takashi Yokoo
Journal:  Clin Exp Nephrol       Date:  2017-08-02       Impact factor: 2.801

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.